Peri-arrest arrhythmias

British Journal of Anaesthesia

Volumn 79, Issue 2, 1997, Pages 198-202

  Chamberlain, D ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Complications, arrhythmia; Complications, cardiac arrest; Heart, arrhythmia

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATROPINE; BRETYLIUM; DIGOXIN; ESMOLOL; FLECAINIDE; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; ORCIPRENALINE; POTASSIUM CHLORIDE; PROCAINAMIDE; VERAPAMIL;

ALGORITHM; BRADYCARDIA; HEART ARREST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; SHORT SURVEY; TACHYCARDIA; TREATMENT PLANNING;

EID: 0030871893     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/79.2.198     Document Type: Review

References (25)

1. Advanced Cardiac Life Support Committee of the ERC. Management of peri-arrest arrhythmias. Resuscitation 1994; 28: 151-159.
2. Advanced Cardiac Life Support Committee of the ERC. Peri-arrest arrhythmias: notice of 1st update. Resuscitation 1996; 31: 281.
3. Bacaner MB. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. American Journal of Cardiology 1968; 21: 530-543.
4. Bastuli JA, Orlowski JP. Stroke as a complication of carotid sinus massage. Critical Care Medicine 1985; 13: 869.
5. Camm AJ, Malcolm AD, Garratt CJ. Adenosine and cardiac arrhythmias. The preferred treatment for supraventricular tachycardia. British Medical Journal 1992; 305: 3-4.
6. Chamberlain DA, Turner P, Sneddon JM. Effects of atropine on heart-rate in healthy man. Lancet 1967; ii: 12-15.
7. Desilva RA, Graboys TB, Podrid PJ, Lown B. Cardioversion and defibrillation. American Heart Journal 1980; 100: 881-895.
8. Falk RH, Zoll PM, Zoll RH. Safety and efficacy of noninvasive pacing. New England Journal of Medicine 1983; 309: 1166-1168.
9. Frishman WH. β-Adrenergic-receptor blockers. Adverse effects and drug interactions. Hypertension 1988; 11 (Suppl. II): 21-29.
10. Griffith MJ, Garratt CJ, Mounsey P, Camm AJ. Ventricular tachycardia as default diagnosis in broad complex tachycardia. Lancet 1994; 343: 386-388.
11. Gulamhusein S, Ko P, Klein GJ. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. American Heart Journal 1983; 106: 145-147.
12. Hayes LJ, Lerman BB, DiMarco JP. Nonventricular arrhythmias as precursors of ventricular fibrillation in patients with out-of-hospital cardiac arrest. American Heart Journal 1989; 118: 53-57.
13. Horowitz LN, Zipes DP, eds. A symposium: Perspectives on proarrhythmia. American Journal of Cardiology 1987; 59: 1E-56E.
14. Lima JJ, Goldfarb AL, Conti DR, Golden LH, Bascomb BL, Benedetti GM, Jusko WJ. Safety and efficacy of procainamide infusions. American Journal of Cardiology 1979; 43: 98-105.
15. Nordrehaug JE, von der Lippe G. Hypokalaemia and ventricular fibrillation in acute myocardial infarction. British Heart Journal 1983; 50: 525-529.
16. Mason JW. Amiodarone. New England Journal of Medicine 1987; 316: 455-466.
17. Oates JA, Wood AJ. Propafenone. New England Journal of Medicine 1990; 322: 518-525.
18. Porter CJ, Gillette PC, Garson A, Hesslein PS, Karpawich PP, McNamara DG. Effects of verapamil on supraventricular tachycardia in children. American Journal of Cardiology 1991; 48: 487-491.
19. Rankin AC, Rae AP, Cobbe SM. Misuse of intravenous verapamil in patients with ventricular tachycardia. Lancet 1987; ii: 472-474.
20. Roden DM, Woolsley RI. Drug therapy: flecainide. New England Journal of Medicine 1986; 315: 36-41.
21. Schützenberger WM, Leisch F, Kerschner K, Harringer W, Herbinger W. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. British Heart Journal 1989; 62: 367-371.
22. Sclarovsky S, Kracoff OH, Agmon J. Acceleration of ventricular tachycardia induced by a chest thump. Chest 1981; 80: 596-599.
23. Turlapaty P, Laddu A, Murthy S, Singh B, Lee R. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings. American Heart Journal 1987; 114: 866-885.
24. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. American Journal of Cardiology 1990; 65: 1397-1399.
25. Wellens HJJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 1972; 46: 216-226.